Inactive Instrument

diaDexus, Inc. Stock OTC Bulletin Board

Pharmaceuticals

End-of-day quote OTC Bulletin Board
- ^USD	-

21-09-17	Diadexus, Inc. Went Out of Business	CI
18-06-08	Motion for Asset Sale Approved for Diadexus, Inc.	CI

Diadexus, Inc. is a diagnostics company. The Company is engaged in developing and commercializing products that deliver healthcare providers with relevant information to assist in the management of patients throughout the course of cardiac disease. Its capabilities include manufacturing, assay development, Food and Drug Administration (FDA) regulatory clearance, and marketing and selling products. Its commercially-available products consist of two FDA-cleared tests to measure Lp-PLA2: the PLAC Test ELISA Kit (the PLAC ELISA Test) and the PLAC Test for Lp-PLA2 Activity (the PLAC Activity Test). Its other products include proADM; proET-1, which aids in predication of heart failure, and proANP, which aids in predication of heart failure. The Company sells its diagnostic products to laboratories and promotes these products to the laboratories' sales representatives, as well as directly to healthcare providers.

Employees

Sector

Pharmaceuticals

More about the company

Market Cap	49.2K 42.32K 39.82K 36.34K 67.81K 4.66M 68.16K 471K 182K 2.38M 185K 181K 7.56M	P/E 2014	-3.26x	P/E 2015	-1.14x
Enterprise Value	5.29M 4.55M 4.28M 3.91M 7.29M 502M 7.33M 50.61M 19.6M 256M 19.86M 19.43M 813M	EV / Sales 2014	1.05x	EV / Sales 2015	0.77x
Free-Float	100%	Yield 2014 *	-	Yield 2015	-

21-09-17	Diadexus, Inc. Went Out of Business	CI
18-06-08	Motion for Asset Sale Approved for Diadexus, Inc.	CI
18-05-09	Motion for Asset Sale Filed by Diadexus, Inc.	CI
16-07-31	Diazyme Laboratories, Inc. completed the acquisition of operational assets from Diadexus, Inc. (OTCPK:DDXS.Q).	CI
16-07-29	Motion for Asset Sale Approved for Diadexus, Inc.	CI
16-07-28	General Atomics Corp. entered into purchase agreement to acquire operational assets from Diadexus, Inc. (OTCPK:DDXS.Q) for $4.8 million.	CI
16-07-19	Cleveland HeartLab, Inc. cancelled the acquisition of operational assets from Diadexus, Inc. (OTCPK:DDXS.Q).	CI
16-07-07	Motion for Asset Sale Filed by Diadexus, Inc.	CI
16-07-06	Cleveland HeartLab, Inc. agreed to acquire operational assets from Diadexus, Inc. (OTCPK:DDXS.Q) for $7 million.	CI
16-06-13	Diadexus, Inc. Filed for Bankruptcy	CI
16-06-10	Diadexus, Inc. Announces Resignation of Leone Patterson as Chief Financial Office	CI
16-05-23	Diadexus, Sonic Healthcare USA Sign National Agreement for PLAC Activity Test	CI
16-04-29	Diadexus, Inc. Reports Unaudited Earnings Results for the First Quarter Ended March 31, 2016	CI

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
SAREPTA THERAPEUTICS, INC.	-6.93%	-0.43%	+11.92%	-82.84%	2.38B
ULTRAGENYX PHARMACEUTICAL INC.	-2.75%	-40.98%	-53.24%	-63.83%	1.5B
BIONOTE, INC.	-2.09%	-1.89%	-17.46%	-8.41%	358M
DK LIFE SCIENCE CO., LTD.	-0.88%	-2.18%	-48.03%	-	53.8M
Average	-3.16%	-8.93%	-26.70%	-51.69%	1.07B
Weighted average by Cap.	-4.99%	-9.92%	-14.11%	-69.80%

	2014	2015
Net sales	26.11M 22.46M 21.13M 19.28M 35.99M 2.48B 36.18M 250M 96.76M 1.27B 98.02M 95.91M 4.01B	17.88M 15.38M 14.47M 13.21M 24.65M 1.7B 24.78M 171M 66.27M 867M 67.13M 65.69M 2.75B
Net income	-8.47M -7.28M -6.85M -6.25M -11.67M -803M -11.73M -81M -31.38M -410M -31.78M -31.1M -1.3B	-7.17M -6.16M -5.8M -5.29M -9.88M -679M -9.93M -68.56M -26.55M -347M -26.9M -26.32M -1.1B
Net Debt	-198K -170K -160K -146K -273K -18.77M -274K -1.89M -734K -9.6M -743K -727K -30.44M	5.24M 4.51M 4.24M 3.87M 7.22M 497M 7.26M 50.14M 19.42M 254M 19.67M 19.25M 806M

diaDexus, Inc. Stock OTC Bulletin Board

Stocks

Pharmaceuticals

Valuation : diaDexus, Inc.

Latest news : diaDexus, Inc.

Diagnostic & Testing Substances Manufacturers

Financials

Company Profile